Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Share-based Compensation Growth (1y) (2010 - 2025)

Analysis

Bio-Rad Laboratories (BIO) Share-based Compensation Growth (1y) (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn 1.23%
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn 2.20%
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn -50.00%
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn 5.80%
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn 5.90%
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 14.95%
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn -
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn 818.21%
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn -7.05%
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.05%
Sep 30, 2025 -4.49%
Dec 31, 2024 1.23%
Sep 30, 2024 -1.89%
Dec 31, 2023 -10.50%
Sep 30, 2023 1.27%
Dec 31, 2022 20.67%
Sep 30, 2022 19.85%
Jun 30, 2022 19.30%
Mar 31, 2022 15.38%
Dec 31, 2021 21.95%
Sep 30, 2021 21.30%
Jun 30, 2021 29.55%
Mar 31, 2021 20.62%
Dec 31, 2020 20.59%
Sep 30, 2020 18.68%
Jun 30, 2020 12.82%
Mar 31, 2020 14.12%
Dec 31, 2019 18.60%
Sep 30, 2019 28.17%